Devex: One trend in access to medicines may be cause for concern
“Five companies are carrying out 63 percent of the most urgently needed global health research and development projects in the priority areas of malaria, HIV/AIDS, tuberculosis, Chagas disease, and leishmaniasis. But having just a handful of companies responsible for most of the progress can jeopardize access to medicines, according to the 2018 Access to Medicines Index, which was released on Monday…” (Cheney, 11/20).